- Home
- KRYS vs PLXS Comparison
KRYS vs PLXS Comparison
Compare KRYS & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- PLXS
- Stock Information
- Founded
- KRYS 2015
- PLXS 1979
- Country
- KRYS United States
- PLXS United States
- Employees
- KRYS N/A
- PLXS N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- PLXS Electrical Products
- Sector
- KRYS Health Care
- PLXS Technology
- Exchange
- KRYS Nasdaq
- PLXS Nasdaq
- Market Cap
- KRYS 4.3B
- PLXS 3.7B
- IPO Year
- KRYS 2017
- PLXS 1986
- Fundamental
- Price
- KRYS $150.49
- PLXS $137.26
- Analyst Decision
- KRYS Strong Buy
- PLXS Strong Buy
- Analyst Count
- KRYS 10
- PLXS 5
- Target Price
- KRYS $204.90
- PLXS $154.50
- AVG Volume (30 Days)
- KRYS 422.6K
- PLXS 159.4K
- Earning Date
- KRYS 08-04-2025
- PLXS 10-22-2025
- Dividend Yield
- KRYS N/A
- PLXS N/A
- EPS Growth
- KRYS 36.22
- PLXS 47.80
- EPS
- KRYS 4.91
- PLXS 5.87
- Revenue
- KRYS $359,205,000.00
- PLXS $4,025,169,000.00
- Revenue This Year
- KRYS $34.33
- PLXS $3.54
- Revenue Next Year
- KRYS $47.84
- PLXS $8.05
- P/E Ratio
- KRYS $30.77
- PLXS $23.32
- Revenue Growth
- KRYS 116.08
- PLXS 2.31
- 52 Week Low
- KRYS $122.80
- PLXS $103.43
- 52 Week High
- KRYS $207.84
- PLXS $172.89
- Technical
- Relative Strength Index (RSI)
- KRYS 56.41
- PLXS 59.73
- Support Level
- KRYS $142.51
- PLXS $126.86
- Resistance Level
- KRYS $147.58
- PLXS $132.67
- Average True Range (ATR)
- KRYS 4.78
- PLXS 3.22
- MACD
- KRYS 0.39
- PLXS 0.61
- Stochastic Oscillator
- KRYS 92.81
- PLXS 89.35
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About PLXS Plexus Corp.
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.